Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures [Phase 4]
Phase 4 clinical trial evaluating the efficacy of combining romosozumab and denosumab for postmenopausal osteoporosis with multiple fragilit…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis
Clinical trial update indicating recruitment for a study on stress urinary incontinence and sarcopenia in postmenopausal osteoporosis.
-
FDA approval · 2024-12-05FDA Approved: CALCITONIN SALMON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's Calcitonin Salmon as an original application (ANDA 212675), enabling the marketing of this generic ca…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women [NA]
A completed clinical trial evaluated DHEA augmentation of musculoskeletal adaptations to exercise in older women. The study focused on condi…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
A completed clinical trial evaluating a weekly effervescent tablet formulation of alendronate after denosumab discontinuation in postmenopau…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-06FDA Approved: TERIPARATIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Teriparatide (teriparatide), enabling marketing of a generic teriparatide product. This act…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis [Phase 3]
Phase 3 study comparing RGB-14-P to Prolia in postmenopausal osteoporosis has completed and posted results.
-
FDA approval · 2024-10-23FDA Approved: ESTRADIOL — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic estradiol product under an original application.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk [Phase 1]
Phase 1 trial investigating blackcurrants showed potential effects on gut microbiota. The study also reported reduced risk markers for postm…
-
FDA approval · 2024-09-27FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ALENDRONATE SODIUM by Aurobindo Pharma Limited (generic).
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis
A clinical trial evaluating how health literacy affects exercise habits and medication adherence in postmenopausal osteoporosis. It is curre…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HLX14 versus Denosumab (Prolia) in postmenopausal osteoporosis at high fracture risk has…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Preventing Osteoporosis Using Denosumab [Phase 4]
Phase 4 clinical trial results for denosumab in preventing osteoporosis have been posted after study completion.
-
EMA approval · 2024-09-16EMA Authorised: Bonviva (ibandronic acid) — Atnahs Pharma Netherlands B.V.
The EMA authorised Bonviva (ibandronic acid) for osteoporosis, including postmenopausal osteoporosis. The marketing authorization holder is …
-
FDA approval · 2024-08-26FDA Approved: ESTRADIOL — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Estradiol by Zydus Pharmaceuticals USA Inc., associated with the generic product's approval upda…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic Women [NA]
A completed clinical trial comparing agility exercise versus resistance exercise to improve physical function and balance in women with post…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) [Phase 3]
Phase 3 trial comparing alendronate and raloxifene in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) [Phase 3]
A Phase 3 trial comparing alendronate and risedronate to assess their effects on bone mineral density in postmenopausal osteoporosis; the st…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) [Phase 3]
A Phase 3 trial update assessing the safety and tolerability of MK0217 in women with postmenopausal osteoporosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) [Phase 3]
A Phase 3 study (MK-0217-907) and its 12-month extension evaluating two investigational drugs for postmenopausal osteoporosis has completed.
-
FDA approval · 2024-08-02FDA Approved: LYLLANA — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for LYLLANA (estradiol) submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Circulating miRNA in Primary Hyperparathyroidism
A completed University of Pennsylvania clinical trial investigates circulating microRNAs as biomarkers in primary hyperparathyroidism, with …
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies
A trial sponsored by the National and Kapodistrian University of Athens aims to identify novel biomarkers and therapeutic targets for osteop…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Kinesiophobia in Postmenopausal Osteoporosis
The clinical trial investigating kinesiophobia in postmenopausal osteoporosis has completed. Sponsor: Beylikduzu State Hospital.
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Effect of GLP-1 Receptor Agonists on Trabecular Bone Score [Phase 2]
Phase 2 trial evaluating the effect of GLP-1 receptor agonists on trabecular bone score in postmenopausal osteoporosis and type 2 diabetes; …